WOCKPHARMA

HealthcareDrug Manufacturers - Specialty & GenericLarge Cap
Wockhardt Limited

Wockhardt Limited operates as a pharmaceutical and biotech company, manufacturing and trading pharmaceuticals, medicinal chemical, and botanical products globally. It develops vari...

हिन्दी में

Wockhardt Limited एक फार्मास्युटिकल और बायोटेक कंपनी के रूप में काम करती है, जो विश्व स्तर पर फार्मास्युटिकल्स, औषधीय रसायन और वानस्पतिक उत्पादों का निर्माण और व्यापार करती है। यह ...

₹2,150.4-1.19%1D
Previous trading day close · Data updates after market close
1W: +1.6%
1M: -2.6%
6M: +57.0%
1Y: +47.3%
44/100
Below AvgResearch Score
Market Cap
₹31.9K Cr
Large Cap
P/E Ratio
85.37
Premium
P/B Ratio
7.17
Premium
ROE
-1.1%
Weak
ROCE
6.4%
Average
Debt / Equity
0.42
Low debt
Div. Yield
N/A
EV/EBITDA
49.88
Expensive
52W Low: ₹1,086.7Current: ₹2,150.452W High: ₹2,422.3
At 80% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
43/100
Growth
Revenue, EPS, profit growth
54/100
Valuation
PE, PB, EV/EBITDA vs sector
18/100
Risk
Debt levels, volatility, coverage
58/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
85.37(Premium)
Forward P/E
N/A
P/B Ratio
7.17(Premium)
P/S Ratio
9.57(Expensive)
EV/EBITDA
49.88(Expensive)
Dividend Yield
N/A
5Y CAGR
31.6%(High growth)
Revenue Growth
25.9%(High)
Profitability
ROE
-1.1%(Average)
ROCE
6.4%(Average)
ROA
-0.6%(Average)
Net Margin
11.2%(Decent)
EBITDA Margin
20.3%
Financial Health
Debt to Equity
0.42(Low debt)
Current Ratio
1.21(Tight)
Quick Ratio
0.85(Tight)
Interest Coverage
2.14x(Low)
Technical Indicators
Based on previous trading day close
RSI (14)
59(Neutral)
RSI Exp (14)
29(Oversold)
MACD
34.342(Bullish)
MACD Signal
49.877
BB Position
45%(Middle)
BB Width
15.47%(Normal)
ADX (14)
21.7(Weak trend)
Williams %R
-58.7(Neutral)
MFI (14)
67(Neutral)
CCI (20)
-9(Neutral)
Stoch %K
41(Neutral)
ATR (14)
95.88(Avg True Range)
OBV (M)
129.6(Positive)
1W OBV Chg
-1.5%(Decreasing)
Rel Volume
0.52x(Normal)
Volatility
53.3%(High)
Max DD 1Y
-39.9%(Moderate)
Alpha (CAPM)
55.23%(Outperforming Nifty)
Return vs Nifty
55.2%(Beating Nifty)
EMA 200
1765.7
EMA 50
2049.0
SMA 200
1666.5
vs SMA 50
6.0%(Above SMA50)
vs SMA 200
29.0%(Above SMA200)
Volume
4.63L
Avg Vol 3M
9.0L
Shareholding Pattern
Promoter
49.1%
Moderate
FII
7.1%
DII / MF
11.0%
Share WOCKPHARMA
Share this stock analysis with your network
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.